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Normal hematopoietic stem cells express not only hematopoietic tissue-specific genes, but also genes expressed in various other normal tissues (1) (2) (3) . In addition to the ability for self renewal, normal hematopoietic stem cells thus have transcription accessibility for genes expressed in non-hematopoietic tissues and this can explain the plasticity of these normal stem cells (4) (5) (6) . Studies on the chromosomes (7-10) and other properties (11, 12) of cancer cells have shown that cancers also have self renewing stem cells (7) (8) (9) (10) (11) (12) . It was therefore of interest to determine whether cancer stem cells have the ability to express genes that are expressed in different normal tissues and how expression of such genes can be regulated under different conditions. To address this question we have used a cloned line of mouse myeloid leukemic cells (M1-t-p53) (4, 13, 14) that contains a temperature sensitive mutant p53 (V135A) protein which changes from a mutant form at 37ºC to wild-type form at 32ºC (15) . Like the parental M1 myeloid leukemia cells (16) (17) (18) (19) , M1-tp53 cells can be induced to undergo myeloid cell differentiation by the cytokine IL-6.
When transferred from 37ºC to 32ºC, activation of wild-type p53 in M1-t-p53 cells induces apoptosis that can be effectively inhibited by IL-6 and the calcium mobilizer thapsigargin (TG) (13, 14, 18, 20) .
We have previously used these cells for microarray analysis of changes in gene expression after activation of p53 in the absence or presence of IL-6 or TG (20) . This analysis showed that p53-induced apoptosis can be inhibited without affecting expression of p53 regulated genes. IL-6 and TG inhibited p53 induced apoptosis by different pathways of gene expression, and IL-6 and TG induced expression of different hematopoietic differentiation-associated genes (20) . DNA microarray analysis of gene expression in a panel of 45 normal mouse tissues has shown that about 80% of the genes 3 are differentially expressed and that there are specific gene expression profiles in different normal tissues (21) . We have now compared the gene expression in M1-t-p53 cells to the profile of gene expression in this panel of 45 normal mouse tissues. Our results indicate that these myeloid leukemic cells express genes that are preferentially expressed in different normal non-hematopoietic tissues, and that activation of p53 and treatment with IL-6 or TG can induce expression of other such non-hematopoietic genes.
These leukemic cells thus share with normal hematopoietic stem cells the capacity to express genes that are expressed in different normal non-hematopoietic tissues.
Materials and Methods
Cells. We have used M1-t-p53 mouse myeloid leukemic cells that express a temperaturesensitive p53 protein that changes from a mutant to wild-type form after transfer from 37ºC to 32ºC (15) and induces apoptosis at 32ºC but not at 37ºC (4, 13, 14, 18, 20) . The cells were cultured and treated with IL-6 or TG as described (20) . Growth curves at 37ºC and the formation of colonies from single cells show that M1-t-p53 and the parental M1 leukemic cells can self-renew (22) .
Analysis of tissue-specific gene expression profiles. Two DNA microarray datasets were used: in the first dataset, mRNA expression levels of genes in M1-t-p53 mouse myeloid leukemic cells (20) were measured using the Affymetrix U74Av2 array, including 12,488 probe sets. In the second dataset, mRNA expression profiles of genes in 45 normal mouse tissues (21) were examined using the Affymetrix U74A array, including 12,588 probe sets. There were 9,977 probe sets in common between the two microarrays. For both datasets, the expression value for each gene was determined using first centered and normalized such that the mean of its component is set to 0, and the sum of squares is set to 1 as described (25) .
We have previously found 1786 genes whose expression changed after activation of wild-type p53 in these leukemic cells in the absence or presence of IL-6 (20) . Because the data sets of M1-t-p53 cells and the normal mouse tissues were obtained using slightly different microarrays, only 1497 of the above 1786 M1-t-p53 genes could be compared to the data from mouse tissues. To search for tissue-specific expression, the genes with low variability of expression between tissues were filtered out of these 1497 genes as described above, and the selected genes were clustered, using SPC, according to their expression in the different mouse tissues. We have also carried out the same procedure of filtering and SPC clustering with 275 additional genes that were up-regulated >2-fold in at least 2 time points in M1-t-p53 cells after p53 activation in the absence or presence of TG.
Results

Initial expression of non-hematopoietic normal tissue-specific genes in M1-t-p53
myeloid leukemic cells. To search for initially expressed genes in M1-t-p53 cells that are preferentially expressed in normal non-hematopoietic tissues, we compared a selected group of highly expressed genes in M1-t-p53 cells (20) to their expression profile in 45 normal mouse tissues (21) . Out of the 12488 genes represented in the microarray, 1857
genes expressed in the M1-t-p53 cells at levels >314 Affymetrix fluorescence units, 85 th percentile, were selected and 1613 of these genes were also present in the data set of Su et al. (21) . These 1613 genes were then filtered to remove those genes that showed low variability of expression level in the 45 normal tissues, as described in Materials and
Methods. This filtration detected 547 differentially expressed genes that were clustered according to their relative expression in different normal tissues. This clustering showed 38 genes in clusters that are preferentially expressed in normal hematopoietic tissues 6 including bone and bone marrow (c1) or bone, bone marrow, lymph node, spleen and thymus (c2 and c3) (Fig. 1 ). In addition, M1-t-p53 cells also expressed 122 genes (22.3%) in clusters that are preferentially expressed in various non-hematopoietic tissues including neuronal tissues such as brain, dorsal root ganglia, spinal cord and some other neuronal tissues (cluster b, 58 genes), skeletal muscle, heart and brown fat (cluster a, 40 genes), liver, kidney and gall bladder (clusters d1 and d2, 13 genes) and testis (cluster e, 11 genes) ( Fig. 1 ) (see the list of genes in Table 2 , which is published as supporting information on the PNAS web site). We tested for dependence of our findings on the (arbitrary) choice of using the upper 15% of expression values, and found that the (20) . To determine whether these 1786 genes include genes that are preferentially expressed in normal non-hematopoietic tissues, we first filtered out those genes that showed a low variability in expression levels in the 45 normal tissues, as described in Materials and Methods. This filtration process detected 578 genes that showed differential expression in different tissues. Clustering these 578 genes according to expression in different tissues identified 6 major clusters showing different patterns of tissue-specific gene expression (Fig. 2 ) (see the list of genes in these clusters and their regulation by activated p53 and IL-6 in Table 3 , which is published as supporting information on the PNAS web site). The largest cluster (c) contained 68 genes preferentially expressed in hematopoietic tissues. This cluster can be sub-divided into two clusters, one (c1) preferentially expressed in bone marrow and bone and the other (c2) expressed in bone marrow, bone, lymph nodes, spleen, thymus, and also in trachea and adipose tissues (Fig. 2) . The other clusters of genes expressed in these leukemic cells contained genes whose profiles showed preferential expression in different normal nonhematopoietic tissues. These clusters include genes preferentially expressed in neuronal tissues (cluster f, 39 genes), testis (cluster a, 37 genes), skeletal muscle, heart and brown fat (cluster b, 29 genes), liver, kidney and gall bladder (cluster d, 24 genes) and digits and epidermis (cluster e, 7 genes) (Fig. 2) .
We also carried out a similar filtration of the 275 genes selected as described in Materials and Methods, whose expression was up-regulated in the myeloid leukemic cells by p53 in the absence or presence of TG. This filtration gave 116 up-regulated genes that were differentially expressed in normal tissues, which were clustered as above. Here the analysis also identified several clusters of genes showing different expression profiles in normal tissues (Fig. 3 ) (see the list of genes in these clusters and their regulation by activated p53 or TG in Table 4 , which is published as supporting information on the PNAS web site). These clusters included genes preferentially expressed in hematopoietic tissues (clusters b and c, 21 genes), neuronal tissues (cluster a, 16 genes), skeletal muscle, 8 heart and brown fat (cluster d, 7 genes), testis (cluster e, 4 genes) and liver and gall bladder (cluster f, 4 genes) (Fig. 3) .
Comparison of the lists of 578 and 116 genes that were analyzed in the last two experiments showed 74 common genes. Thus, out of the 578+116-74=620 genes whose expression was changed in M1-t-p53 myeloid leukemic cells by p53, IL-6 or TG and which showed differential expression in different normal mouse tissues, 21.3% (132 genes) were preferentially expressed in non-hematopoietic tissues. Out of these 132 nonhematopoietic genes, p53 up-regulated expression of 59 genes, IL-6 up-regulated 10 genes and TG up-regulated 14 genes. Examples of genes up-regulated by p53, IL-6 and TG are given in Table 1 Analysis of gene expression in mouse and human normal tissues has shown that about 80% of the genes show a differential expression in different tissues, which can be used to identify tissue specific gene expression profiles (21) . We searched for genes that are initially highly expressed in M1-t-p53 leukemic cells and are preferentially expressed in normal non-hematopoietic tissues. We found 122 such genes in clusters whose expression profile showed preferential expression in different normal non-hematopoietic tissues including neuronal tissues, muscle, liver and testis. These results indicate that like normal hematopoietic stem cells, these leukemic cells express genes that are expressed in non-hematopoietic normal tissues.
The use of M1-t-p53 myeloid leukemic cells enabled us to determine the regulation of expression of non-hematopoietic genes under different conditions including after activation of wild-type p53 and treatment with IL-6 or TG. We found 620 genes whose expression in the leukemic cells changed under these conditions and which were differentially expressed in different normal tissues. Out of these 620 genes, 132 genes were preferentially expressed in different normal non-hematopoietic tissues that also included neuronal tissues, muscle, liver and testis. Out of these 132 genes, 59 genes were up-regulated in the leukemic cells by p53, 10 by IL-6 and 14 by TG. Only 9 out of these 132 non-hematopoietic tissue-specific genes, whose expression was regulated by p53, IL-6 or TG, were among the 122 non-hematopoietic tissue-specific genes initially expressed in M1-t-p53 cells. Our results indicate that in addition to the 122 genes that are preferentially expressed in non-hematopoietic tissues and were initially expressed in the leukemic cells, p53, IL-6 and TG could reprogram these cells to change expression of other genes that are preferentially expressed in normal non-hematopoietic tissues.
The major mechanism for the transcription accessibility in the leukemic cells for genes normally expressed in non-hematopoietic tissues, presumably involves changes in DNA methylation and other epigenetic changes (19, (27) (28) (29) (30) (31) . Induction of DNA demethylation and inhibition of histone deacetylase activity by deoxycytidine and trichostatin A, respectively, can up-regulate expression of many genes that are silenced in cancer cells (32) . It will be interesting to determine whether genes that are up-regulated by such compounds in cancer cells also include genes that are preferentially expressed in normal tissues other than the tissue in which the cancer originated. Alternative splicing may also play a role in expression of non-hematopoietic genes in the leukemic cells. One of the genes that is preferentially expressed in a non-hematopoietic tissue and is upregulated by p53 in the M1-t-p53 leukemic cells (20) Table by its name, GeneBank accession number and fold-up-regulation by p53, IL-6 or TG. Fold upregulation is from results described in Lotem et al. (20) . All the genes regulated by p53, IL-6 and TG are shown in Tables 3 and 4 , which are published as supporting information on the PNAS web site. 
